Literature DB >> 32716767

Resource Allocation in COVID-19 Research: Which Trials? Which Patients?

Sarah Wieten1, Alyssa Burgart1,2, Mildred Cho1,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32716767     DOI: 10.1080/15265161.2020.1779392

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  5 in total

1.  How COVID-19 changed clinical research strategies: a global survey.

Authors:  Annina Bauer; Anja Eskat; Atara Ntekim; Creany Wong; Deborah Eberle; Elham Hedayati; Fabian Tay; Henry Yau; Louise Stockley; María de Medina Redondo; Selçuk Şen; Silvia Egert-Schwender; Yağız Üresin; Regina Grossmann
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

Review 2.  Conducting clinical research in the era of the COVID-19 pandemic: Challenges and lessons for Speech-Language Pathology and Audiology research.

Authors:  Katijah Khoza-Shangase; Nomfundo Monroe; Ben Sebothoma
Journal:  S Afr J Commun Disord       Date:  2022-07-18

3.  Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis.

Authors:  Wojciech Margas; Piotr Wojciechowski; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2022-08-09

Review 4.  Cochleovestibular findings linked to COVID-19: A scoping review for clinical care planning in South Africa.

Authors:  Katijah Khoza-Shangase
Journal:  S Afr J Commun Disord       Date:  2022-08-12

5.  The impact of COVID-19 on speech-language and hearing professions in low- and middle-income countries: Challenges and opportunities explored.

Authors:  Katijah Khoza-Shangase; Nomfundo Moroe; Joanne Neille; Anita Edwards
Journal:  S Afr J Commun Disord       Date:  2022-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.